UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Hepatitis C infection: the quest for new treatment strategies
Weegink, C.J.
Publication date
2004
Link to publication
Citation for published version (APA):
Weegink, C. J. (2004). Hepatitis C infection: the quest for new treatment strategies. s.l.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.
Contents
Chapter 1 General introduction 9 Chapter 2 Aims of the studies 33 Chapter 3 Sustained virological response in chronic hepatitis C patients 35
after a 6- and a 36-month interferon- a2b treatment schedule A multicentrer, randomized, controlled study
Chapter 4 Predictive factors for response and non-response in naive 55 chronic hepatitis C patients treated with interferon-a/ribavirin
combination therapy or interferon-a monotherapy for 24 weeks A randomized, double blind, placebo-controlled study
Chapter 5 Development of myasthenia gravis during treatment 69 of chronic hepatitis C with interferon-alpha and ribavirin
Chapter 6 Viral kinetics of HCV RNA in patients with chronic hepatitis C 73 treated with 18 MU Interferon alpha daily
Chapter 7 Chronic hepatitis C patients with a post-treatment virological relapse 87 retreated with an induction dose of 18 MU interferon-a
in combination with ribavirin and amantadine A two-arm randomized pilot study
Chapter 8 Retreatment of chronic hepatitis C non-responder patients 105 with 18 MU daily interferon-a induction in combination with
ribavirin and/or amantadine A pilot study
Chapter 9 A physician with a positive HCV-RNA test after a needle stick injury 119
Chapter 10 Summary 125 Samenvatting voor niet-ingewijden 128
Dankwoord 136
